ST. PAUL, Minn.--(BUSINESS WIRE)--St. Jude Medical, Inc. (NYSE:STJ), a global medical device company, today announced subset data results for the Angio-Seal™ Evolution™ Vascular Closure Device ...
ST. PAUL, Minn.--(BUSINESS WIRE)--Nov. 10, 2003--St. Jude Medical, Inc. (NYSE:STJ) today announced the launch of the Angio-Seal(TM) Millennium Platform vascular closure device for sale in Japan. As ...
Recently published results from the Cardiovascular and Interventional Radiological Society of Europe (“CIRSE”) vascular closure device registry further validated the safety and efficacy of medical ...
Kensey Nash originally developed Angio-Seal, and St. Jude bought the marketing and manufacturing rights for the device from Tyco International in early 1999. "Angio-Seal will now be marketed by one of ...
ST. PAUL, Minn., March 17 (UPI) -- St. Jude Medical said Friday it has launched its newly approved vascular closure device to seal arteries in surgery. The device maker said the Angio-Seal VIP -- ...
SAN FRANCISCO (MarketWatch) -- Kensey Nash Corp. after Tuesday's closing bell said that it has executed a new supply contract with St. Jude Medical Inc. for the Angio-Seal vascular closure device ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback